Form 4: Rocket Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4
John Militello, Vice President of Finance, Treasurer, and Principal Accounting Officer of Rocket Pharmaceuticals, sold 718 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- On April 22, 2025, John Militello, an officer at Rocket Pharmaceuticals, sold 718 shares of common stock at a price of $7.158 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Militello directly owns 65,039 shares of Rocket Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and has no inherent positive or negative implications for the company's overall outlook.
Industry Context
Sales of shares by company executives are a normal part of corporate governance. Often these sales are to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 04/22/2025 | Date of the transaction (sale of shares). |
| 04/24/2025 | Date of signature on the Form 4 filing. |
Keywords
Rocket Pharmaceuticals, John Militello, Form 4, share sale, tax obligations, RSUs, officer, RCKT
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.